Neutrophil extracellular trap as a predictive marker to cisplatin-based chemotherapy for patients with muscle-invasive bladder cancer

被引：0
|
作者：
Shang, Bing-Qing
Gu, Zhaoru
Qu, Wang
Xie, Rui-Yang
Wu, Jie
Zhou, Ai-Ping
Shou, Jianzhong
机构：
[1] Chinese Acad Med Sci & Peking Union, Dept Urol, Natl Canc Ctr, Natl Clin Res Ctr Canc,Canc Hosp, Beijing, Peoples R China
[2] Chinese Acad Med Sci & Peking Union Med Coll, Dept Etiol & Carcinogenesis, Natl Canc Ctr,Canc Hosp, State Key Lab Mol Oncol,Natl Clin Res Ctr Canc, Beijing, Peoples R China
[3] Chinese Acad Med Sci & Peking Union Med Coll, Dept Med Oncol, Natl Canc Ctr, Natl Clin Res Ctr Canc,Canc Hosp, Beijing, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e16600
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Genomic Differences Between "Primary" and "Secondary" Muscle-invasive Bladder Cancer as a Basis for Disparate Outcomes to Cisplatin-based Neoadjuvant Chemotherapy
    Pietzak, Eugene J.
    Zabor, Emily C.
    Bagrodia, Aditya
    Armenia, Joshua
    Hu, Wenhuo
    Zehir, Ahmet
    Funt, Samuel
    Audenet, Francois
    Barron, David
    Maamouri, Noelia
    Li, Qiang
    Teo, Min Yuen
    Arcila, Maria E.
    Berger, Michael F.
    Schultz, Nikolaus
    Dalbagni, Guido
    Herr, Harry W.
    Bajorin, Dean F.
    Rosenberg, Jonathan E.
    Al-Ahmadie, Hikmat
    Bochner, Bernard H.
    Solit, David B.
    Iyer, Gopa
    EUROPEAN UROLOGY, 2019, 75 (02) : 231 - 239
  • [32] Chemotherapy for Muscle-Invasive Bladder Cancer
    Trenta, Patrizia
    Calabro, Fabio
    Cerbone, Linda
    Sternberg, Cora N.
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2016, 17 (01) : 1 - 14
  • [33] Neoadjuvant chemotherapy with cisplatin and methotrexate in patients with muscle-invasive bladder tumours
    Sengelov, L
    von der Maase, H
    Lundbeck, F
    Barlebo, H
    Colstrup, H
    Engelholm, SA
    Krarup, T
    Madsen, EL
    Meyhoff, HH
    Mommsen, S
    Nielsen, OS
    Pedersen, D
    Steven, K
    Sorensen, B
    ACTA ONCOLOGICA, 2002, 41 (05) : 447 - 456
  • [34] Defining cisplatin eligibility in patients with muscle-invasive bladder cancer
    Jiang, Di Maria
    Gupta, Shilpa
    Kitchlu, Abhijat
    Meraz-Munoz, Alejandro
    North, Scott A.
    Alimohamed, Nimira S.
    Blais, Normand
    Sridhar, Srikala S.
    NATURE REVIEWS UROLOGY, 2021, 18 (02) : 104 - 114
  • [35] Defining cisplatin eligibility in patients with muscle-invasive bladder cancer
    Di Maria Jiang
    Shilpa Gupta
    Abhijat Kitchlu
    Alejandro Meraz-Munoz
    Scott A. North
    Nimira S. Alimohamed
    Normand Blais
    Srikala S. Sridhar
    Nature Reviews Urology, 2021, 18 : 104 - 114
  • [36] Defining molecular and laboratory predictive biomarkers of response to cisplatin-based neoadjuvant chemotherapy (NC) in muscle-invasive bladder cancer (MIBC) - preliminary results and future plans
    Leibowitz-Amit, Raya
    Seah, Jo-An
    Berger, Raanan
    Sridhar, Srikala S.
    CANCER RESEARCH, 2014, 74 (19)
  • [37] The utility of neoadjuvant gemcitabine plus carboplatin followed by immediate radical cystectomy in patients with muscle-invasive bladder cancer who are ineligible for cisplatin-based chemotherapy
    Hiromi Murasawa
    Takuya Koie
    Chikara Ohyama
    Hayato Yamamoto
    Atsushi Imai
    Shingo Hatakeyama
    Takahiro Yoneyama
    Yasuhiro Hashimoto
    Ikuya Iwabuchi
    Masaru Ogasawara
    Toshiaki Kawaguchi
    International Journal of Clinical Oncology, 2017, 22 : 159 - 165
  • [38] Prediction of Response to Cisplatin-Based Neoadjuvant Chemotherapy of Muscle-Invasive Bladder Cancer Patients by Molecular Subtyping including KRT and FGFR Target Gene Assessment
    Ecke, Thorsten H.
    Voss, Paula Carolin
    Schlomm, Thorsten
    Rabien, Anja
    Friedersdorff, Frank
    Barski, Dimitri
    Otto, Thomas
    Waldner, Michael
    Veltrup, Elke
    Linden, Friederike
    Hake, Roland
    Eidt, Sebastian
    Roggisch, Jenny
    Heidenreich, Axel
    Rieger, Constantin
    Kastner, Lucas
    Hallmann, Steffen
    Koch, Stefan
    Wirtz, Ralph M.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (14)
  • [39] The utility of neoadjuvant gemcitabine plus carboplatin followed by immediate radical cystectomy in patients with muscle-invasive bladder cancer who are ineligible for cisplatin-based chemotherapy
    Murasawa, Hiromi
    Koie, Takuya
    Ohyama, Chikara
    Yamamoto, Hayato
    Imai, Atsushi
    Hatakeyama, Shingo
    Yoneyama, Takahiro
    Hashimoto, Yasuhiro
    Iwabuchi, Ikuya
    Ogasawara, Masaru
    Kawaguchi, Toshiaki
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2017, 22 (01) : 159 - 165
  • [40] Potential utility of a 4-marker immunohistochemistry panel to predict response to cisplatin-based neoadjuvant chemotherapy in patients with muscle-invasive bladder cancer: a single-center preliminary experience
    Morselli, Simone
    Campi, Riccardo
    Gacci, Mauro
    Sebastianelli, Arcangelo
    Fattorini, Caterina
    Villari, Donata
    Carini, Marco
    Minervini, Andrea
    Serni, Sergio
    Raspollini, Maria R.
    MINERVA UROLOGY AND NEPHROLOGY, 2021, 73 (04): : 424 - 427
12345